LUng CAncer focuS - Long-term Monitoring of Bronchogenic Carcinoma Patients (LUCAS)
NCT ID: NCT04228237
Last Updated: 2022-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2300 participants
OBSERVATIONAL
2018-06-01
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Outcomes and Costs (HOC) in Lung Cancer (LC)
NCT02363101
LALUCA Research Platform A Prospective Analysis of Lung Cancer Diagnosis and Management in Clinical Practice
NCT04733430
Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project
NCT02613637
Early Detection of Lung Cancer in Czech High-risk Asymptomatic Individuals
NCT04627350
Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
NCT06833632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This monitoring is non-interventional, so the usual diagnostic and therapeutic procedures will be used according to the decision of the physician. All patients with bronchogenic carcinoma diagnosed from June 1, 2018 will be enrolled with up to 60 months of follow-up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
OAKS Consulting s.r.o.
UNKNOWN
Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martina Koziar Vasakova, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Thomayer hospital Prague
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital Brno
Brno, , Czechia
University hospital Hradec Kralove
Hradec Králové, , Czechia
University hospital Olomouc
Olomouc, , Czechia
University hospital Plzen
Pilsen, , Czechia
University Thomayer hospital
Prague, , Czechia
University hospital Motol
Prague, , Czechia
University hospital Bulovka
Prague, Česká Republika, Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Venclicek O, Skrickova J, Brat K, Fischer O, Havel L, Hrnciarik M, Marel M, Opalka P, Krakorova G, Rozsivalova D, Kultan J, Mullerova A, Zarnayova L, Smickova P, Vasakova M, Gyorfy Z, Jirousek M, Krejci D, Krejci J, Zuna P, Svaton M, Hrda K, Duba J, Alahakoon J, Svoboda M, Silar J. Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry. Anticancer Res. 2021 Nov;41(11):5549-5556. doi: 10.21873/anticanres.15368.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPFS/Reg18.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.